Cellebrite DI Ltd. (CLBT)
Statistics
Share Statistics
Cellebrite DI has 249.44M shares outstanding. The shares have a market value of 3.8B.
| 249.44M | |
| 15.35% | |
| 0.48% | |
| 51.04% | |
| 120.7M | |
| 195,280 | |
| n/a |
Short Selling Information
Short interest in Cellebrite DI is 3.27% of the outstanding shares, representing 8.15M shares. The short ratio is 5.15.
| 8.15M | |
| 3.27% | |
| 5.84% | |
| 5.15 |
Valuation Ratios
The stock has a PE ratio of 54.46, meaning that every $1 in earnings is currently priced at $54.46 in the stock market.
| 54.46 | |
| 23.07 | |
| 7.66 | |
| 5.7 | |
| 7.36 | |
| 25.1 | |
| n/a |
Enterprise Valuation
The enterprise value is 3.54B. Enterprise value adds debt and subtracts cash from the company's market cap, providing an alternative valuation for the company.
| 7.14 | |
| 44.55 | |
| 20.54 | |
| 23.39 |
Financial Position
Cellebrite DI's current ratio is 1.54. A current ratio above 1 means that the company has enough short-term assets to cover its short-term liabilities.
| 1.54 | |
| 1.43 | |
| 0.04 | |
| 0.19 | |
| 0.15 | |
| 194.2 |
Financial Efficiency
Return on Equity is 16.44%, and return on invested capital is 19.04%.
| 16.44% | |
| 4.76% | |
| 19.04% | |
| $386.32K | |
| $55.93K | |
| 1,285 | |
| 0.52 | |
| 10.64 |
Taxes
| 13.12M | |
| 15.44% |
Stock Price Statistics
The stock price has increased by 14.58% in the past year.
| 1.18 | |
| 14.58% | |
| 14.62 | |
| 15.19 | |
| 62.91 | |
| 1,955,030 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of 496.43M and earned 71.86M in profits. Earnings per share was 0.28.
| 496.43M | |
| 416.32M | |
| 63.33M | |
| 71.86M | |
| 117.81M | |
| 101.57M | |
| 0.28 |
Balance Sheet
Cellebrite DI has 133.69M in cash on the balance sheet. Total assets are 952.29M, and total liabilities are 22.8M.
| 133.69M | |
| 22.8M | |
| 110.88M | |
| -75.6M | |
| 952.29M | |
| 190.66M |
Cash Flow
Cellebrite DI's operating cash flow was 172.55M over the trailing twelve months.
| 172.55M | |
| -20.99M | |
| 151.56M | |
| 0.608 |
Margins
Cellebrite DI's gross profit margin was 83.86%, while its operating and net profit margins were 12.76% and 14.48%, respectively.
| 83.86% | |
| 12.76% | |
| 17.12% | |
| 14.48% | |
| 23.73% | |
| 20.46% | |
| 30.53% |
Analyst Forecast
According to 7 stock analysts, the average 12-month price target for Cellebrite DI is $21. The average analyst rating is "Strong Buy".
| $21 | |
| 37.7% | |
| Strong Buy | |
| 7 |
Fair Value
There are several formulas that can be used to estimate the fair value of a stock. The Graham Number estimates a fair value of $3.59, representing a potential upside of -76.46%.
| $5.37 | |
| -64.79% | |
| 3.59 | |
| -76.46% |
Scores
| 6.17 | |
| 4 |